| 000 | 01720 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514003037.0 | ||
| 264 | 0 | _c20011101 | |
| 008 | 200111s 0 0 eng d | ||
| 022 | _a0171-6425 | ||
| 024 | 7 |
_a10.1055/s-2001-14287 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMirow, N | |
| 245 | 0 | 0 |
_aClinical use of heparin-coated cardiopulmonary bypass in coronary artery bypass grafting. _h[electronic resource] |
| 260 |
_bThe Thoracic and cardiovascular surgeon _cJun 2001 |
||
| 300 |
_a131-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Evaluation Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 | _aCardiopulmonary Bypass |
| 650 | 0 | 4 | _aCoronary Artery Bypass |
| 650 | 0 | 4 |
_aCoronary Disease _xcomplications |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aHemorrhage _xetiology |
| 650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLength of Stay |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _xetiology |
| 650 | 0 | 4 |
_aParesis _xetiology |
| 650 | 0 | 4 |
_aPostoperative Complications _xetiology |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aProtamines _xtherapeutic use |
| 650 | 0 | 4 |
_aRenal Insufficiency _xetiology |
| 650 | 0 | 4 |
_aStroke _xetiology |
| 700 | 1 | _aMinami, K | |
| 700 | 1 | _aKleikamp, G | |
| 700 | 1 | _aTenderich, G | |
| 700 | 1 | _aPuhlmann, T | |
| 700 | 1 | _aKörfer, R | |
| 773 | 0 |
_tThe Thoracic and cardiovascular surgeon _gvol. 49 _gno. 3 _gp. 131-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-2001-14287 _zAvailable from publisher's website |
| 999 |
_c11361700 _d11361700 |
||